2 completed, 1 unknown, 1 withdrawn. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Hydroxypropyl methylcellulose: new trials by email Literature Review of Hydroxypropyl methylcellulose trials Research Report on Hydroxypropyl methylcellulose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy Oxytocin, Hydroxypropyl methylcellulose - Vaginal Atrophy, Genitourinary Syndrome of Menopause | Phase 3 | Unknown | Oxagon | 244 | 2024-09-01 | 2024-07-23 |
| Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers YJ001 for Spray Use, Placebo of YJ001 for Spray Use - Safety and Tolerability | Phase 1 | Completed | Yuejia Pharmaceuticals (USA), Inc. | 32 | 2022-08-15 | 2023-01-04 |
| Parasitic Ulcer Treatment Trial Pilot Chlorhexidine, Povidone-Iodine, Prednisolone Sodium Phosphate - Acanthamoeba Keratitis | Phase 2 | Completed | University of California, San Francisco | 49 | 2018-01-01 | 2026-05-07 |
| Efficacy Study of Ketorolac and HPMC to Treat Dry Eye Ketorolac/HPMC, HPMC, Vehicle - Dry Eye | Phase 2 | Withdrawn | ORA, Inc. | 2009-03-01 | 2024-04-24 |
Acanthamoeba Keratitis (1) · Atrophy (1) · Dry Eye Syndromes (1)
ORA, Inc. (1) · Oxagon (1) · University of California, San Francisco (1) · Yuejia Pharmaceuticals (USA), Inc. (1)
United States (2) · Egypt (1) · India (1)
Assem Anwar (1) · H. Jerome Crampton, MD (1) · Jeremy D Keenan, MD (1)